Utility of Multi-Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation
Darin T. Okuda, Tatum M. Moog, Morgan C. McCreary, Isabella J. Huddleston, Crystal M. Wright, Katy W. Burgess, Jose R. Santoyo, Peter V. Sguigna, Olaf Stüve, Diem H. Tran · 2026
Read Utility of Multi-Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation by Darin T. Okuda, Tatum M. Moog, Morgan C. McCreary, Isabella J. Huddleston, Crystal M. Wright, Katy W. Burgess, Jose R. Santoyo, Peter V. Sguigna, Olaf Stüve, Diem H. Tran (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13615235.txt.
Description
Darin T. Okuda leads a team testing in 2026 a commercial blood test that measures many proteins. It may tell a true multiple sclerosis relapse from a pseudo-flare. A pseudo-flare is a worsening of old symptoms without new immune attack. Telling them apart decides whether a patient needs steroids or a change of treatment. The study looked back at patients at one university clinic who had both the blood test and an MRI scan before any steroid treatment.
One group had fresh symptoms that raised fear of a relapse, while a second group came for routine checks, some on approved disease drugs and some not. Matching protein results against scan findings showed how far the blood test agrees with the picture inside the brain. A reliable blood check could spare patients extra scans and speed the right call during a scare.
Catalog record
| CREATOR | Darin T. Okuda, Tatum M. Moog, Morgan C. McCreary, Isabella J. Huddleston, Crystal M. Wright, Katy W. Burgess, Jose R. Santoyo, Peter V. Sguigna, Olaf Stüve, Diem H. Tran |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37654 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |